Skip to content

Study on the Effect of Ginseng Guben Oral Liquid in Preventing Postoperative Fatigue in Patients Undergoing Abdominal Surgery

Study on the Effect of Ginseng Guben Oral Liquid in Preventing Postoperative Fatigue in Patients Undergoing Abdominal Surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093153
Enrollment
Unknown
Registered
2024-11-29
Start date
2023-10-27
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative fatigue in patients undergoing abdominal surgery

Interventions

Trial Group:Starting from the first day after surgery, oral administration of Ginseng Guben Oral Liquid or nasogastric feeding via gastric tube, 10ml each time, once in the morning and once in the eve
Control Group:Starting from the first day after surgery, placebo liquid was orally administered or nasogastric feeding was administered via a gastric tube, 10ml each time, once in the morning and once

Sponsors

The Second Hospital, Cheeloo College of Medicine, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 years and <= 70 years, without surgical contraindications, and in the perioperative period; 2. Hepatobiliary surgery patients who undergo open surgery and fourth level laparoscopic surgery; 3. Patients without serious internal medicine diseases, mental illnesses, or a history of major surgeries; 4. Patients who are conscious, have no communication difficulties, have good compliance, and voluntarily accept the survey.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, lung, brain, liver, and kidney dysfunction after surgery; 2. Patients who experience significant postoperative complications and are unable to take medication regularly; 3. Patients with poor postoperative compliance who are expected to have difficulty in normal follow-up; 4. Patients who cannot tolerate drugs or experience significant side effects and give up participating in clinical trials.

Design outcomes

Primary

MeasureTime frame
Perioperative fatigue level;

Secondary

MeasureTime frame
Fatigue state;Fatigue expression rating;

Countries

China

Contacts

Public ContactLiu Chongzhong

The Second Hospital, Cheeloo College of Medicine, Shandong University

Lczk1980@163.com+86 176 6008 8868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026